Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy

Int Urol Nephrol. 2019 Oct;51(10):1781-1782. doi: 10.1007/s11255-019-02227-w. Epub 2019 Jul 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Biopsy
  • Clinical Decision-Making
  • Humans
  • Male
  • Middle Aged
  • Multiparametric Magnetic Resonance Imaging*
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / pathology*
  • Reoperation